FLT3 and acute myeloid leukemia: Our results are consistent with this, Dec and Aza enhanced the cytotoxicity of CD44v6 CAR-T against AML cells in vitro and in vivo, by promoting CD44v6 expression in AML cells regardless of FLT3 or DNMT3A mutations.